医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Investigator Initiated Trials is Topic of New Handbook Sponsored by Quintiles

2015年01月23日 PM12:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

Quintiles today announced the launch of a handbook to guide physicians in the conduct of investigator initiated clinical trials. Top clinical researchers from academia and industry across Asia-Pacific joined Quintiles’ experts in contributing to and editing the handbook, which Quintiles sponsored as part of its ongoing efforts to enhance clinical research globally and create a healthier world.

Availability of the handbook, “Investigator Initiated Trials Made Easy,” was announced at a press conference held at Seoul National University Hospital in South Korea.

“Investigator initiated, patient-focused clinical trials play a vital role in improving and expanding patient care in the real world,” said Dr. Stephanie Tan, MBBS, Quintiles Site and Patient Network, Asia, the handbook’s co-editor and primary coordinator. “This innovative, collaborative effort between academia and industry is designed to provide physicians the theoretical and practical foundation needed to conduct their own trials.”

Joining Dr. Tan at the press conference was co-editor Prof. Yung-Jue Bang, president of Seoul National University Hospital’s Biomedical Research Institute and director of its Clinical Trial Center. The third co-editor, Prof. K. Arnold Chan, director of National Taiwan University Hospital’s Clinical Trial Center (Taipei), was unable to attend the launch.

Prof. Bang said: “This handbook represents the consolidated expertise of 20 authors from across the world, many of whom are thought-leading investigators in their field. We came together because we want to advance medicine and improve patients’ lives through high-quality investigator initiated trials. We hope this handbook will be a stepping stone to more investigator-led clinical research into the treatment of diseases affecting patients in Asia-Pacific and around the world.”

At the press conference, Dr. Amar Kureishi, Quintiles Regional Chief Medical Officer and head of Drug Development Asia, said: “It gives us immense pleasure to see the creation of this handbook, which provides the basic tools for physicians to pursue scientific enquiry in their own institutions and in their own practices for the benefit of patients everywhere.”

To request a PDF copy of the handbook, visit www.quintiles.com/IIT-Made-Easy.

About Quintiles

Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top- 100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.

Appendix – Contributing Authors

1. Professor Yung-Jue Bang MD, PhD (Seoul National University Hospital, South Korea)

2. Professor K. Arnold Chan MD, ScD, FISPE (National Taiwan University Hospital, Taiwan)

3. Dr. Stephanie Tan, MBBS (Quintiles, Singapore)

4. Professor Danny Liew, BMedSc, MBBS (Hons), PhD, FRACP (Royal Melbourne Hospital, Australia)

5. Professor Ock-Joo Kim MD, PhD (Seoul National University Hospital, South Korea)

6. Professor Pik Pin Goh MD, FRCS (Clinical Research Centre, Ministry of Health, Malaysia)

7. Associate Professor Sith Sathornsumtee MD (Siriraj Hospital, Thailand)

8. Dr. Lye Mun Tho MBBS, MRCP, FRCR, PhD (Private Practice, Malaysia)

9. Dr. Sheau Wen Lok MBBS, FRACP (Walter and Eliza Hall Institute of Medical Research, Australia)

10. Dr. Jana Baskar MBBS, MBA, GradDipPharmMed, MMedSc (Novartis Pharmaceuticals, Australia)

11. Dr. Nantha Kumar MBBS (Pharmaceutical Company, Singapore)

12. Dr. Loke Meng Ong MBBS, FRCP (Clinical Research Center, Penang Hospital,, Malaysia)

13. Dr Amir Kalali MD (Quintiles, USA)

14. Dr Vikas Sharma MBBS, MD(Quintiles, India)

15. Dr Kerry Gordon PhD (Quintiles, United Kingdom)

16. Srinivas Pai Raikar (Quintiles, Singapore)

17. Raghavendra Kalmadi (Quintiles, India)

18. Lisa Marie Saldanha (Quintiles, Singapore)

19. David Horsburgh (Quintiles, Singapore)

20. Lilian Chan (Quintiles, Singapore)

Click here to subscribe to Mobile Alerts for Quintiles.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150122005017/en/

CONTACT

Quintiles
Media Relations
Jay Johnson, +65.9655.6635, jay.johnson@quintiles.com
or
Investor
Relations
Karl Deonanan, +1.919.998.2789, InvestorRelations@quintiles.com
www.quintiles.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表